The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study



      Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to hepatic inflammation to cirrhosis. We sought to identify common genetic variants contributing to NAFLD, using CT measured fatty liver (FL), and alanine aminotransferase levels (ALT), as a biochemical marker of hepatic inflammation.


      We employed a correlated meta-analysis (CMA) to test whether combining FL and ALT genomewide association (GWA) results, using ∼2.5 million imputed SNPs, could enhance ability to detect variants influencing both traits.


      Variants of the ERLIN1-CHUK-CWF19L1 gene cluster were associated with concomitant variation of FL and ALT. Nine variants (rs2862954, rs1408579, rs10883451, rs11597086, rs11591741, rs17729876, rs17668255, rs17668357, rs12784396) displayed genomewide significant associations at loci concomitantly influencing FL and ALT (2.47 × 10−9 ≤ CMA-p ≤ 4.29 × 10−10) as compared with the suggestive significance of marginal tests (4.11 × 10−5 ≤ GWA-p ≤ 2.34 × 10−6). For example, the missense variant in ERLIN1-rs2862954 was genomewide significant (CMA-p = 4.88 × 10−10) for the combination of FL and ALT, while the respective univariate associations were suggestive (FL:p = 5.74 × 10−6, ALT:p = 3.71 × 10−6). Further we investigated whether the concomitant associations were driven mainly by ALT levels. When we adjusted FL by ALT, the correlated associations diminished but did not vanish (CMA-p ≤ 3.3 × 10−7). Our findings suggest ERLIN1-CHUK-CWF19L1 variants are associated with early stage of FL accumulation (measured by CT) to hepatic inflammation (ALT levels), and the association enhances when accounting for the correlations between their scans.


      CMA approach enhanced the ability to identify novel variants of the ERLIN1-CHUK-CWF19L1 influencing both simple steatosis and hepatic steatosis with inflammation, which suggest that this gene cluster may regulate the susceptibility of NAFLD in a wide spectrum of disease.


      • Correlated meta-analysis improves the power to detect variants associated with NAFLD.
      • NAFLD was assessed by using CT measured fatty liver and ALT levels.
      • Correlated meta-analysis identifies association of ERLIN1-CHUK-CWF19L1 with NAFLD.
      • Liver fat deposition and liver inflammation are associated with ERLIN1-CHUK-CWF19L1.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lewis J.R.
        • Mohanty S.R.
        Nonalcoholic fatty liver disease: a review and update.
        Dig Dis Sci. 2010; 55: 560-578
        • Musso G.
        • Gambino R.
        • Cassader M.
        Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
        Prog Lipid Res. 2009; 48: 1-26
        • Schwenzer N.F.
        • Springer F.
        • Schraml C.
        • Stefan N.
        • Machann J.
        • Schick F.
        Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
        J Hepatol. 2009; 51: 433-445
        • Boyce C.J.
        • Pickhardt P.J.
        • Kim D.H.
        • et al.
        Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.
        AJR Am J Roentgenol. 2010; 194: 623-628
        • Yamada J.
        • Tomiyama H.
        • Yambe M.
        • et al.
        Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.
        Atherosclerosis. 2006; 189: 198-205
        • Schindhelm R.K.
        • Diamant M.
        • Dekker J.M.
        • Tushuizen M.E.
        • Teerlink T.
        • Heine R.J.
        Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
        Diabetes Metab Res Rev. 2006; 22: 437-443
        • Speliotes E.K.
        • Yerges-Armstrong L.M.
        • Wu J.
        • et al.
        Genomewide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
        PLoS Genet. 2011; 7: e1001324
        • Yuan X.
        • Waterworth D.
        • Perry J.R.
        • et al.
        Population-based genomewide association studies reveal six loci influencing plasma levels of liver enzymes.
        Am J Hum Genet. 2008; 83: 520-528
        • Makkonen J.
        • Pietiläinen K.H.
        • Rissanen A.
        • Kaprio J.
        • Yki-Järvinen H.
        Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins.
        J Hepatol. 2009; 50: 1035-1042
        • Romeo S.
        • Kozlitina J.
        • Xing C.
        • et al.
        Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
        Nat Genet. 2008; 40: 1461-1465
        • Kotronen A.
        • Johansson L.E.
        • Johansson L.M.
        • et al.
        A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.
        Diabetologia. 2009; 52: 1056-1060
        • Sookoian S.
        • Castaño G.O.
        • Burgueño A.L.
        • Gianotti T.F.
        • Rosselli M.S.
        • Pirola C.J.
        A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.
        J Lipid Res. 2009; 50: 2111-2116
        • Rotman Y.
        • Koh C.
        • Zmuda J.M.
        • Kleiner D.E.
        • Liang T.J.
        NASH CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
        Hepatology. 2010; 52: 894-903
        • Devries M.C.
        • Samjoo I.A.
        • Hamadeh M.J.
        • Tarnopolsky M.A.
        Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women.
        Obes (Silver Spring). 2008; 16: 2281-2288
        • Higgins M.
        • Province M.
        • Heiss G.
        • et al.
        NHLBI Family Heart Study: objectives and design.
        Am J Epidemiol. 1996; 143: 1219-1228
        • Carr J.J.
        • Nelson J.C.
        • Wong N.D.
        • et al.
        Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.
        Radiology. 2005; 234: 35-43
        • Giannini E.G.
        • Testa R.
        • Savarino V.
        Liver enzyme alteration: a guide for clinicians.
        CMAJ. 2005; 172: 367-379
        • Kraja A.T.
        • Vaidya D.
        • Pankow J.S.
        • et al.
        A bivariate genomewide approach to metabolic syndrome: STAMPEED consortium.
        Diabetes. 2011; 60: 1329-1339
        • Price A.L.
        • Patterson N.J.
        • Plenge R.M.
        • Weinblatt M.E.
        • Shadick N.A.
        • Reich D.
        Principal components analysis corrects for stratification in genomewide association studies.
        Nat Genet. 2006; 38: 904-909
        • Province M.A.
        • Borecki I.B.
        A correlated meta-analysis strategy for data mining “OMIC” scans.
        PSB, 2013 (Online Proceedings on press:)
        • Borecki I.B.
        • Province M.A.
        Genetic and genomic discovery using family studies.
        Circulation. 2008; 118: 1057-1063
        • Pruim R.J.
        • Welch R.P.
        • Sanna S.
        • et al.
        LocusZoom: regional visualization of genomewide association scan results.
        Bioinformatics. 2010; 26: 2336-2337
        • Browman D.T.
        • Resek M.E.
        • Zajchowski L.D.
        • Robbins S.M.
        Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER.
        J Cell Sci. 2006; 119: 3149-3160
        • Calder P.C.
        • Yaqoob P.
        Lipid rafts–composition, characterization, and controversies.
        J Nutr. 2007; 137: 545-547
        • Li N.
        • Huang X.
        • Zhao Z.
        • Chen G.
        • Zhang W.
        • Cao X.
        Identification and characterization of a novel gene KE04 differentially expressed by activated human dendritic cells.
        Biochem Biophys Res Commun. 2000; 279: 487-493
        • Nseir W.
        • Shalata A.
        • Marmor A.
        • Assy N.
        Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
        Dig Dis Sci. 2011; 56: 3439-3449
        • Malaguarnera M.
        • Di Rosa M.
        • Nicoletti F.
        • Malaguarnera L.
        Molecular mechanisms involved in NAFLD progression.
        J Mol Med. 2009; 87: 679-695
        • Flowers M.T.
        • Ntambi J.M.
        Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
        Curr Opin Lipidol. 2008; 19: 248-256
        • Kotronen A.
        • Seppänen-Laakso T.
        • Westerbacka J.
        • et al.
        Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.
        Diabetes. 2009; 58: 203-208
        • Stefan N.
        • Peter A.
        • Cegan A.
        • et al.
        Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.
        Diabetologia. 2008; 51: 648-656
        • Flowers M.T.
        • Keller M.P.
        • Choi Y.
        • et al.
        Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet.
        Physiol Genomics. 2008; 33: 361-372
        • Ciba I.
        • Widhalm K.
        The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
        Acta Paediatr. 2007; 96: 109-112